ImpediMed Limited
IPDQF
$0.0375
$0.017587.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.95% | 15.74% | 25.57% | 28.51% | -4.81% |
| Total Other Revenue | -- | -- | -- | -- | -71.97% |
| Total Revenue | 17.95% | 15.74% | 25.57% | 28.51% | -4.02% |
| Cost of Revenue | 47.09% | 44.32% | 13.45% | 16.09% | -8.47% |
| Gross Profit | 13.86% | 11.73% | 27.42% | 30.40% | -3.36% |
| SG&A Expenses | 8.03% | 6.01% | -6.37% | -4.18% | -5.55% |
| Depreciation & Amortization | 110.40% | 106.45% | 89.59% | 94.02% | -17.88% |
| Other Operating Expenses | -30.92% | -32.21% | 65.38% | 69.22% | 20.47% |
| Total Operating Expenses | 8.70% | 6.66% | 2.47% | 4.86% | -2.02% |
| Operating Income | -3.90% | -1.95% | 6.47% | 4.28% | 0.95% |
| Income Before Tax | -16.70% | -14.52% | -14.81% | -17.49% | -2.32% |
| Income Tax Expenses | 11.63% | 9.30% | -44.62% | -43.08% | 59.26% |
| Earnings from Continuing Operations | -16.70% | -14.51% | -14.68% | -17.36% | -2.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.70% | -14.51% | -14.68% | -17.36% | -2.37% |
| EBIT | -3.90% | -1.95% | 6.47% | 4.28% | 0.95% |
| EBITDA | -4.15% | 0.87% | 16.43% | 14.48% | 1.01% |
| EPS Basic | -18.75% | -18.75% | -- | -- | 11.11% |
| Normalized Basic EPS | -20.00% | -20.00% | -- | -- | 9.09% |
| EPS Diluted | -18.75% | -18.75% | -- | -- | 11.11% |
| Normalized Diluted EPS | -20.00% | -20.00% | -- | -- | 9.09% |
| Average Basic Shares Outstanding | 0.22% | 0.22% | 0.15% | 0.15% | 11.21% |
| Average Diluted Shares Outstanding | 0.22% | 0.22% | 0.15% | 0.15% | 11.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |